[US]

• Caution: This product contains Natural Rubber Latex Which May

Anti-Human Globulin Cause Allergic Reactions.
• Warning: Contains sodium azide (NaN3), which may react with lead
Anti-IgG or copper plumbing to form explosive azides. If discarded in the sink,
flush with large amounts of water to prevent the build-up of
(Rabbit) explosive metal azides.
Does not Contain Antibodies to Complement Components • The bovine albumin used for the production of this reagent is
purchased from BSE-free US sources, Boval Company L.P. in
FOR IN-VITRO DIAGNOSTIC USE Cleburne, Tx, USA and Millipore in Kankakee, IL, USA.
For Tube Testing
MEETS FDA POTENCY REQUIREMENTS Specimen Collection
U.S. License Number: 1798 Fresh samples of clotted or EDTA anticoagulated whole blood can be
used for the indirect antiglobulin test. EDTA or citrate anticoagulated
Package size whole blood samples must be used for the direct antiglobulin test,
[REF] 804175100 [VOL] 10 x 10 mL Anti-Human Globulin Anti-IgG weak D test or crossmatch. Samples collected following standard blood
sampling guidelines are acceptable. The specimen should be tested as
soon as possible after collection. If testing is delayed, EDTA and
Intended Use clotted specimens should be stored at 2 to 8°C, citrated specimens
Anti-Human Globulin Anti-IgG is used for the direct antiglobulin test to (donor segments) at 1 to 6°C. Stored samples should be allowed to
demonstrate the in-vivo coating of red blood cells with antibody reach room temperature prior to testing. Use of samples older than ten
molecules (such as autoantibodies, maternal antibodies in hemolytic days should be avoided unless there is no other alternative since
disease of the newborn, alloantibodies against red cells in transfusion antibody reactivity has been shown to decrease in older samples.
reactions). Blood specimens exhibiting gross hemolysis or contamination should
not be used.
Anti-Human Globulin Anti-IgG is used for the indirect antiglobulin test
to demonstrate the in-vitro coating of red blood cells with antibody Materials
molecules as in the detection and identification of unexpected Materials provided
antibodies as well as crossmatch tests. Furthermore, blood group • Anti-Human Globulin Anti-IgG
antigen typing (with the corresponding test reagent for the indirect
antiglobulin test) can be carried out. Material required but not provided
• Pipettes (drop volume 40 to 50 μL)
Summary
1 • Isotonic saline solution
Moreschi first described the use of Anti-Human Globulin in 1908 .
2,3 • Reagent Red Blood Cells (e.g. Biotest: Biotestcell® 1 & 2 [REF]
Coombs rediscovered the test in 1945. By injecting rabbits with
816014100, Biotestcell® 3 [REF] 816085100, Biotestcell -I 8
®
human IgG, they were able to produce a protein (Anti-IgG) that reacted
[REF] 816020100, Biotestcell -I 11 [REF] 816021100)
®
with incomplete antibodies (IgG). Most “incomplete” antibodies (IgG)
4
fail to agglutinate red blood cells suspended in saline. Most clinically • Donor or patient red blood cells
significant antibodies in red blood cell serology are of the IgG class and • IgG coated red blood cells (e.g. Biotest Coombscell-E [REF]
can only be detected by the use of Anti-IgG. A stable lattice structure is 816030100)
formed and agglutination occurs when Anti-IgG binds to the IgG • LISS (e.g. Biotest MLB2 [REF] 805200100)
sensitized red blood cells. • Glass tubes 10 x 75mm or 12 x 75mm
Biotest Anti-Human Globulin reagents are used to test for the presence • Serological centrifuge
or absence of unexpected red blood cell antibodies. Furthermore,
• Interval Timer
blood group antigen typing (with the corresponding test reagent for the
• Markers
indirect antiglobulin test) can be carried out. Routine pretransfusion
studies always include tests for antibody screening, crossmatch and • Optical aid (optional). The use of an optical aid for agglutination
antibody identification. reading must be vaildated by the user.

Principle of the Test Test Procedure

The test principle is a hemagglutination test. Anti-Human Globulin Anti- A. Indirect Antiglobulin Test (IAT)
IgG acts as a link between the antibody coating of neighbouring red If an enhancement medium (albumin, LISS) is used, please refer to the
blood cells and induces agglutination. Uncoated red blood cells will not respective instructions for use.
agglutinate.
1. Prepare a 3 to 5 % suspension of red blood cells in isotonic saline
Reagent solution.
Anti-Human Globulin Anti-IgG is prepared by immunizing rabbits with 2. Place one drop of red blood cell suspension in an appropriately
human IgG. The anti-IgG component contains antibody reactivity against marked tube and add 2 drops of serum to be tested (or as directed
light chain IgG and thus may also agglutinate IgA or IgM sensitized red for test reagent).
blood cells. There is no activity with complement coated red blood cells. 3. Incubate at 37°C for 30 to 60 minutes or as appropriate to the
The reagent is supplied in a 10 mL glass bottle. enhancement reagent used.
Antibodies are diluted in a isotonic saline solution containing bovine 4. Wash the red blood cells 3 times with isotonic saline. Decant
albumin and as colorant Patent Blue and Tartrazin. supernatant saline completely.
5. Add 2 drops of Anti-Human Globulin Anti-IgG to the packed red
Anti-Human Globulin Anti-IgG (Rabbit) blood cells and mix.
6. Centrifuge for 20 seconds at 800 - 1000 x g.
Preservative: 0.1% sodium azide. 7. Gently dislodge the red blood cell button and observe for
agglutination.
Precautions 8. Record results
• For In-vitro diagnostic use.
B. Direct Antiglobulin Test (DAT)
• Store at 2 to 8°C.
• Do not use beyond the expiration date. 1. Prepare a 3 to 5 % suspension of the red blood cells in isotonic
• Discard reagents that are turbid. saline.
• Do not dilute. 2. Wash one drop of this red blood cell suspension 3 times, with
• Do not use specimens collected with gel separators. isotonic saline solution. Completely decant the supernatant.
• Handle and dispose of reagents as potentially infectious 3. Add 2 drops of Anti-Human Globulin Anti-IgG to the packed red
• Caution: Do not pipette by mouth. The absence of all viruses has not blood cells and mix.
been determined. 4. Centrifuge for 20 seconds at 800 -1000 x g.
5. Gently dislodge the red blood cell button and observe for
agglutination. For the product performance it is necessary to adhere to the
6. Record results recommended method in the instructions for use.

Stability of the Reaction The performance of the Biotest Anti-Human Globulin Anti-IgG was
Following centrifugation, all tube tests should be read immediately and confirmed against a FDA approved reference reagent in a Multi Center
results interpreted without delay. Time delays may cause a dissociation Field Trial.
of the antigen-antibody complexes resulting to false negative or more
often weak positive reactions. For Technical Support or further product information, contact Biotest
Diagnostics Corporation at 800-522-0090.
Quality Control
The reactivity of all reagents should be confirmed by testing with Note
known positive and negative red blood cells on each day of use. Each facility should verify the optimum spin time for the specific centrifuge
To confirm the reactivity or specificity of Biotest Anti-Human Globulin in use.
Anti-IgG, the reagent should be tested with IgG coated and non coated Manual techniques are to be performed according to the
red blood cells respectively. The reagent is satisfactory for use if it manufacturer’s instructions. Each deviation from these instructions is
reacts only with the IgG coated red blood cells. the sole responsibility of the user. Used tests must be discarded as
Negative results in an antiglobulin test should be verified with IgG hazardous material. Manage waste according to national regulations.
coated red blood cells: Add 1 drop of IgG coated red blood cells, mix
and centrifuge for 20 seconds at 800 - 1000 x g. Glossary of Symbols
Positive result: The negative reaction in the indirect antiglobulin test is
valid, reactive Anti-Human Globulin is present. Symbol Definition Symbol Definition
Negative result: A technical error was made and the test must be In vitro diagnostic
repeated. [LOT] Batch Code [IVD]
medical device
It is recommended that a positive and a negative control be performed
Caution, consult
in parallel with testing.
! accompanying I
Consult instructions
for use.
documents
Interpretation of results
Agglutination of the red blood cells with the indirect antiglobulin test is M Manufacturer e Use by
YYYY-MM-DD
a positive result and indicates the presence of an unexpected
antibody(ies). Agglutination of the red blood cells with the direct Contains sufficient
antiglobulin test is a positive result and indicates an auto-agglutinin or s quantity for <n> [REF] Catalog number
tests.
auto antibodies. No agglutination is a negative result and indicates the
absence of an unexpected antibody or the absence of the t Temperature
limitation
[VOL] Volume
corresponding antigen or lack of an auto-agglutinin.
An agglutination viewer may facilitate the reading of tube tests (as
recommended by the AABB Technial Manual, 15th edition). Bibliography
1.Moreschi C. Neue Tatsache über die Blutkörperchen
Limitations Agglutinationen, Zbl Bakt 1908; 46:49,456
• Low frequency antigens may not always be present on reagent red 2.Coombs, RRA, Mourant, AE and Race, RR: “A new test for the
blood cells and a double dose of antigen may be required to detect very detection of weak and “incomplete” Rh agglutinins.” Br J Exp Pathol
weakly reacting antibodies. Therefore, negative reactions with the 26:255, 1945
screening cells do not always indicate the absence of unexpected 3.Coombs, RRA, Mourant AE and Race, RR: “In vivo isosensitization
antibodies. of red blood cells in babies with hemolytic disease.” Lancet i: 264,
• Insufficient or inappropriate washing can lead to false negative or false 1946
positive reactions. Small amounts of residual patient sera/plasma can 4.Pittiglio, D. Harmening. Modern Blood Banking and Transfusion
neutralize the Anti-Human Globulin Anti-IgG. Practices. Philadelphia, PA: F.A. Davis, 1983.
5.Mark E. Brecher, MD et al. Technical Manual 15th Edition, Bethesda,
• There is no anti-complement activity with this product. Cells coated with
MA: AABB, 2005.
complement should not give a positive reaction.
• Some conditions that may cause false positive results are:
- Contamination of sample or reagents
- Autoantibodies
- Improper storage or preparation of red blood cells
- Antibodies to antibiotics or other reagents
- Cold Antibodies
• Positive reactions may be seen from individuals who have received Rh
Immunoglobulin.
• Do not use frozen/deglycerolized and enzyme treated red blood
cells

Specific Performance Characteristics

Testing is performed in accordance with FDA recommended methods.
The final release testing is performed according to the product specific
SOPs. Each lot of Biotest Anti- Human Globulin reagent is tested in the
Quality control by package insert method against IgG and complement
coated red blood cells to insure suitable reactivity. The products meet
FDA potency requirements. The specificity testing for the presence of
contaminating antibodies is performed according to the product specific
SOPs.

187822/04
Rev. 07/2008 M| Biotest Medical Diagnostics GmbH, Industriestr. 1,
| Biotest D-63303 Dreieich, Germany, www.biotest.de, mail@biotest.de
Tel.: +49-6103-801-0, Fax: +49-6103-801-140